Norethindrone

Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.

Cross Reference

Introduction

To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Norethindrone?

Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Norethindrone

MeSH term MeSH ID Detail
Pancreatic Neoplasms D010190 77 associated lipids
Body Weight D001835 333 associated lipids
Arteriosclerosis D001161 86 associated lipids
Total 3

PubChem Associated disorders and diseases

What pathways are associated with Norethindrone

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Norethindrone?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Norethindrone?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Norethindrone?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Norethindrone?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Norethindrone?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Norethindrone

Download all related citations
Per page 10 20 50 100 | Total 3869
Authors Title Published Journal PubMed Link
Reisman H et al. A multicenter randomized comparison of cycle control and laboratory findings with oral contraceptive agents containing 100 microg levonorgestrel with 20 microg ethinyl estradiol or triphasic norethindrone with ethinyl estradiol. 1999 Am. J. Obstet. Gynecol. pmid:10561675
Stadberg E et al. Bioavailability of norethisterone acetate alone and in combination with estradiol administered in single or multiple oral doses to postmenopausal women. 1999 Maturitas pmid:10585174
Rintala S et al. GnRH analogues and uterine leiomyomas. Effect of hormone replacement therapy on cell proliferation. 1999 Gynecol. Obstet. Invest. pmid:10592433
Hassan EO et al. Once-a-month injectable contraceptives, Cyclofem and Mesigyna, in Egypt. Efficacy, causes of discontinuation, and side effects. 1999 Contraception pmid:10592855
Kennedy G et al. Elevated levels of sE-selectin in post-menopausal females are decreased by hormone replacement therapy to levels observed in pre-menopausal females. 1999 Thromb. Haemost. pmid:10595633
Philibert D et al. The pharmacological profile of a novel norpregnance progestin (trimegestone). 1999 Gynecol. Endocrinol. pmid:10599548
Dören M et al. Impact on uterine bleeding and endometrial thickness: tibolone compared with continuous combined estradiol and norethisterone acetate replacement therapy. 1999 Menopause pmid:10614676
Scopacasa F et al. The effects of low dose norethisterone on biochemical variables in postmenopausal women. 1999 Osteoporos Int pmid:10624456
Chantler IW and Davie MW Low dose continuous combined hormone replacement therapy: early and late postmenopausal effect on endometrium. 2000 J Ultrasound Med pmid:10625188
Agrawal R et al. Serum vascular endothelial growth factor concentrations in postmenopausal women: the effect of hormone replacement therapy. 2000 Fertil. Steril. pmid:10632412
Mikkola T et al. Administration of transdermal estrogen without progestin increases the capacity of plasma and serum to stimulate prostacyclin production in human vascular endothelial cells. 2000 Fertil. Steril. pmid:10632415
Kaunitz AM et al. Comparative safety, efficacy, and cycle control of Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension) and Ortho-Novum 7/7/7 oral contraceptive (norethindrone/ethinyl estradiol triphasic). Lunelle Study Group. 1999 Contraception pmid:10640164
Shulman LP et al. Patient acceptability and satisfaction with Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension). 1999 Contraception pmid:10640168
Notelovitz M et al. Efficacy of continuous sequential transdermal estradiol and norethindrone acetate in relieving vasomotor symptoms associated with menopause. 2000 Am. J. Obstet. Gynecol. pmid:10649149
Kamali P et al. Cardiovascular responses of perimenopausal women to hormonal replacement therapy. 2000 Am. J. Obstet. Gynecol. pmid:10649151
Shakespeare J et al. Is norethisterone a lifestyle drug? Results of database analysis. 2000 BMJ pmid:10650028
Zaoral J et al. [Insertion and removal of intravaginal tampons during estrus synchronization in heifers]. 1978 Vet Med (Praha) pmid:106502
Shadle CR et al. A double-blind, placebo-controlled evaluation of the effect of oral doses of rizatriptan 10 mg on oral contraceptive pharmacokinetics in healthy female volunteers. 2000 J Clin Pharmacol pmid:10709161
Edgren RA and Stanczyk FZ Nomenclature of the gonane progestins. 1999 Contraception pmid:10715364
Thorneycroft IH et al. Effect of low-dose oral contraceptives on androgenic markers and acne. 1999 Contraception pmid:10717776
Byrjalsen I et al. Piperazine oestrone sulphate and interrupted norethisterone: effects on the postmenopausal endometrium. 2000 BJOG pmid:10740331
Alexandersen P et al. Piperazine oestrone sulphate and interrupted norethisterone in postmenopausal women: effects on bone mass, lipoprotein metabolism, climacteric symptoms, and adverse effects. 2000 BJOG pmid:10740332
Cromie MA et al. Comparative effects of Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension) and ortho-Novum 7/7/7 oral contraceptive (norethindrone/ethinyl estradiol triphasic) on lipid profiles. Investigators from the Lunelle Study Group. 2000 Contraception pmid:10745070
Cagnacci A et al. Transdermal administration of estradiol and norethisterone: effect on the uterus and uterine arteries. 2000 Mar-Apr Menopause pmid:10746894
Shen Y et al. Regulation of biodegradability and drug release behavior of aliphatic polyesters by blending. 2000 J. Biomed. Mater. Res. pmid:10756311
Gravholt CH et al. Lp(a) and lipids in adult Turner's syndrome: impact of treatment with 17beta-estradiol and norethisterone. 2000 Atherosclerosis pmid:10781652
Cooke I et al. Antifibrinolytics for heavy menstrual bleeding. 2000 Cochrane Database Syst Rev pmid:10796518
Lethaby A et al. Cyclical progestogens for heavy menstrual bleeding. 2000 Cochrane Database Syst Rev pmid:10796587
Lethaby AE et al. Progesterone/progestogen releasing intrauterine systems versus either placebo or any other medication for heavy menstrual bleeding. 2000 Cochrane Database Syst Rev pmid:10796865
Stachenfeld NS et al. Estrogen modifies the temperature effects of progesterone. 2000 J. Appl. Physiol. pmid:10797125
Fraser IS et al. Vaginal epithelial surface appearances in women using vaginal rings for contraception. 2000 Contraception pmid:10802278
Bständig B et al. Effectiveness of low dose of gonadotropin releasing hormone agonist on hormonal flare-up. 2000 J. Assist. Reprod. Genet. pmid:10806591
Teede HJ et al. Postmenopausal hormone replacement therapy increases coagulation activity and fibrinolysis. 2000 Arterioscler. Thromb. Vasc. Biol. pmid:10807761
Owens D et al. Lipoproteins and low-dose estradiol replacement therapy in post-menopausal Type 2 diabetic patients: the effect of addition of norethisterone acetate. 2000 Diabet. Med. pmid:10821298
Verhoeven CH et al. Excretion balance and metabolism of the progestagen Org 30659 in healthy postmenopausal women. 2000 J. Steroid Biochem. Mol. Biol. pmid:10822023
El Bouhmadi A et al. 100 mg acetylsalicylic acid acutely decreases red cell aggregation in women taking oral contraceptives. 2000 Clin. Hemorheol. Microcirc. pmid:10831061
Ozsener S et al. The effect of continuous combined oral estradiol and norethisterone on the renal and internal carotid artery pulsatility indices in postmenopausal women. 2000 Int J Gynaecol Obstet pmid:10854874
Vecchi A et al. Steroid contraceptive agents and immunological reactivity in experimental animals. 1976 Biomedicine pmid:1086685
Ylikorkala O et al. Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol/norethisterone acetate hormone replacement therapy. 2000 Clin Ther pmid:10868559
Ravinder P et al. Biological efficacy and plasma norethisterone levels of orally administered norethisterone enanthate in rat and hamster. 1998 Indian J. Physiol. Pharmacol. pmid:10874348
Spencer CP et al. Effects of oral and transdermal 17beta-estradiol with cyclical oral norethindrone acetate on insulin sensitivity, secretion, and elimination in postmenopausal women. 2000 Metab. Clin. Exp. pmid:10877199
Gonzalo-Lumbreras R and Izquierdo-Hornillos R High-performance liquid chromatographic optimization study for the separation of natural and synthetic anabolic steroids. Application to urine and pharmaceutical samples. 2000 J. Chromatogr. B Biomed. Sci. Appl. pmid:10892579
Halleen JM et al. Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption. 2000 J. Bone Miner. Res. pmid:10893682
Bryant G et al. Is norethisterone a lifestyle drug? Health is not merely the absence of disease. 2000 BMJ pmid:10896441
Lloyd D Is norethisterone a lifestyle drug? It's not a lifestyle drug in North Harrow. 2000 BMJ pmid:10896442
Hamilton W Is norethisterone a lifestyle drug? The term lifestyle is not as clear as it may seem. 2000 BMJ pmid:10896443
Wentz AC et al. Gonadotropin responses following luteinizing hormone releasing hormone administration in normal subjects. 1975 Obstet Gynecol pmid:1089927
Winkler UH et al. Effects of tibolone and continuous combined hormone replacement therapy on parameters in the clotting cascade: a multicenter, double-blind, randomized study. 2000 Fertil. Steril. pmid:10899490
Kaunitz AM Efficacy, cycle control, and safety of two triphasic oral contraceptives: Cyclessa (desogestrel/ethinyl estradiol) and ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol): a randomized clinical trial. 2000 Contraception pmid:10906499
Bassol S et al. Mesigyna once-a-month combined injectable contraceptive: experience in Latin America. 2000 Contraception pmid:10906501